State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China.
Department of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, 60637, USA.
Cell Death Differ. 2018 Sep;25(9):1612-1624. doi: 10.1038/s41418-018-0065-z. Epub 2018 Feb 14.
MicroRNA (miRNA) dysregulation is associated with the tumorigenesis and development of numerous human cancers. The defect in miRNA biogenesis is the main cause of miRNA dysregulation. We previously demonstrated that ERK-induced phosphorylation of XPO5 followed by peptidyl-prolyl cis/trans isomerase Pin1-mediated isomerization downregulates miRNA expression and contributes to hepatocellular carcinoma (HCC) development. However, how Pin1 precisely regulates miRNA biogenesis in HCC remains elusive. Here we reveal that Pin1 has a pivotal role in the miRNA maturation process by modulating phosphorylated Serine-Proline (pS-P) motif of XPO5 in a phosphorylation-dependent manner. By recognizing and binding to XPO5 via its WW domain, Pin1 catalyzes the conformation change of XPO5 and diminishes XPO5 ability to export pre-miRNAs from the nucleus to the cytoplasm, resulting in the reduced mature miRNA levels and promoted HCC development. Furthermore, downregulation of Pin1 by shRNA restores XPO5-dependent pre-miRNA export and effective biogenesis of mature miRNAs, leading to both in vitro and in vivo HCC inhibition. Therefore, our research discloses a new posttranscriptional regulatory mechanism of miRNA biosynthesis and provides the experimental basis for a novel HCC therapy by targeting Pin1.
微小 RNA(miRNA)失调与许多人类癌症的肿瘤发生和发展有关。miRNA 生物发生的缺陷是 miRNA 失调的主要原因。我们之前证明 ERK 诱导的 XPO5 磷酸化,随后是肽基脯氨酰顺/反异构酶 Pin1 介导的异构化,下调 miRNA 的表达,并有助于肝细胞癌(HCC)的发展。然而,Pin1 如何精确调节 HCC 中的 miRNA 生物发生仍然难以捉摸。在这里,我们揭示了 Pin1 通过调节 XPO5 的磷酸化丝氨酸-脯氨酸(pS-P)基序,以磷酸化依赖的方式在 miRNA 成熟过程中发挥关键作用。通过其 WW 结构域识别和结合 XPO5,Pin1 催化 XPO5 的构象变化,并降低 XPO5 将 pre-miRNA 从细胞核输出到细胞质的能力,导致成熟 miRNA 水平降低,并促进 HCC 的发展。此外,通过 shRNA 下调 Pin1 可恢复 XPO5 依赖性 pre-miRNA 输出和成熟 miRNA 的有效生物发生,从而在体外和体内抑制 HCC。因此,我们的研究揭示了 miRNA 生物合成的新转录后调节机制,并为针对 Pin1 的新型 HCC 治疗提供了实验基础。